Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth
Update your Virtual Booth on PharmaCompass, ask us ![]()
About
CPhI WW FrankfurtCPhI WW Frankfurt
Not Confirmed
Not Confirmed
28-30 October, 2025
Not Confirmed
Not Confirmed
26-29 October, 2025
ISPE Annual MeetingISPE Annual Meeting
Not Confirmed
Not Confirmed
26-29 October, 2025
List your booth number for exhibitions, ask us
CONTACT DETAILS






Upload your Marketing & Sales content on your company Virtual Booth, click HERE.
Events
Webinars & Exhibitions
CPhI WW FrankfurtCPhI WW Frankfurt
Industry Trade Show
Not Confirmed
28-30 October, 2025
Industry Trade Show
Not Confirmed
26-29 October, 2025
ISPE Annual MeetingISPE Annual Meeting
Industry Trade Show
Not Confirmed
26-29 October, 2025
Digital content
INTERVIEW #SpeakPharma
[Sponsored by another company]https://www.pharmacompass.com/speak-pharma/we-re-expanding-our-cdmo-capabilities-to-meet-the-next-wave-of-complex-therapies-starting-with-oncology
VLOG #PharmaReel
[Sponsored by another company]DATA COMPILATION #PharmaFlow
[Sponsored by another company]https://www.pharmacompass.com/radio-compass-blog/cdmo-activity-tracker-veranova-chemexpress-invest-in-adc-facilities-cohance-to-set-up-oligonucleotide-facility-in-india

31 Jul 2025
// PR NEWSWIRE
https://www.prnewswire.com/news-releases/chipscreen-biosciences-brain-penetrant-aurora-b-selective-inhibitor-cs231295-tablet-receives-fda-ind-approval-advancing-global-clinical-development-302518530.html

01 Nov 2024
// PR NEWSWIRE
https://www.prnewswire.com/news-releases/the-phase-iii-clinical-trial-application-for-first-line-treatment-of-extensive-disease-small-cell-lung-cancer-with-chiauranib-has-been-approved-302294039.html

17 Oct 2024
// PR NEWSWIRE
https://www.prnewswire.com/news-releases/chipscreen-biosciences-innovative-anti-tumor-drug-cs231295-tablets-investigational-new-drug-ind-application-accepted-302279370.html

15 Oct 2024
// PR NEWSWIRE
https://www.prnewswire.com/news-releases/chiglitazar-for-the-treatment-of-mash-phase-ii-clinical-study-selected-for-oral-presentation-at-the-2024-american-liver-disease-annual-meeting-302276529.html

30 Apr 2024
// PR NEWSWIRE
https://www.prnewswire.com/news-releases/national-medical-products-administration-nmpa-approves-chipscreen-biosciences-chidamide-epidaza-combined-with-r-chop-for-the-treatment-of-diffuse-large-b-cell-lymphoma-302131654.html

18 Mar 2024
// PR NEWSWIRE
https://www.prnewswire.com/news-releases/positive-results-from-phase-ii-clinical-trial-cgz203-study-of-chiglitazar-monotherapy-for-non-alcoholic-steatohepatitis-302091430.html
ABOUT THIS PAGE